IntraBio
PrivateLast Round
VC Round
Mar 25, 2024
Total Funding Raised
$15M
Company Overview
IntraBio is a biopharmaceutical company that develops and commercializes innovative small-molecule therapies for rare and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IntraBio Comparables
Compare IntraBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyclo Therapeutics Inc | 81% | |
| Azafaros | 81% | |
| Zevra Therapeutics | 77% | |
IntraBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 25, 2024 | ||||
| Series C | Apr 5, 2023 | ||||
| VC Round | Nov 5, 2020 | ||||
| VC Round | Aug 20, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 5, 2020
$21M raised in a VC Round.
IntraBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IntraBio's valuation, stock price, and market status.